This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Markets Higher on Strong Earnings, Existing Homes Sales Rise

Markets are still riding high from positive results from Apple (AAPL) and other corporate earnings.

AbbVie Calls Off $55B Deal to Buy Shire, Cites New Treasury Rules

U.S. drugmaker AbbVie announced it is calling off its proposed $55 billion takeover of Irish pharmaceutical company Shire, and will pay an approximately $1.6 billion breakup fee as a result.

Jim Cramer On China's Economic Data: Focus On Baltic Freight

Jim Cramer shares insight on the latest economic data out of China and stresses the importance of focusing on the nation's baltic freight data.

Apple Gets Price Target Boost, BMO Starts Coverage on Ford and GM

Apple (AAPL) gets a price target lift at BMO and Susquehanna starts coverage of Ford (F), General Motors (GM) and TripAdvisor (TRIP) in Tuesday's Analysts' Actions.

Jim Cramer's Take On Apple Stock: Own It, Don't Trade It!

Jim Cramer says Apple is receiving an impressive response from a broad spectrum of retailers for its new Apple Pay mobile payments system.

Real Money Previews

Real Money's Sham Gad: Buffett's Strategy to Cut His Losses on Tesco

Investors can learn from Buffett's recent misstep with Tesco.

Cramer: Buy Small Oil Companies on This Next Leg Down

Big oil should start buying smaller oil.

Real Money's Kate Stalter: Strategizing Your Retirement Fund

Don't stampede into cash at this stage.

Mad Money Recap

'Mad Money' Lightning Round: I'm Not Going Near Plug Power

Cramer thinks RR Donnelley is a good investment, Fiat is doing quite well and prefers Skyworks Solutions over Sierra Wireless.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

Buy These 5 Financial Sector Breakout Stocks in October

Better-than-expected results among financial stocks are helping to propel this sector's outperformance even higher in the second half of the month.

3 Financial Stocks Rising on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

How to Trade the Market's Most-Active Stocks

Here's how to trade some of the most active stocks on the market right now.

4 Huge Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

MainStreet

3 Common (and Increasingly Dangerous) Lies People Tell on Resumes

These three resume lies are harder than some to find out — until your potential employer senses something amiss and makes a few phone calls.

3 Crazy Ways Billionaires Go Bankrupt: Even the Elite Can Topple

If the stock market doesn't sting you, the winery might drain you dry.

Home Sharing Site Expands Network on Expedia to Gain Millennial Appeal

Millennials are increasingly gravitating toward cost-saving accommodations options on their travels by using home sharing services. Mainstream booking platforms are taking note.

Fed Chair Yellen Views Student Loan Crisis as Evidence of an Equality Gap

The student loan crisis develops a new wrinkle.

Airbag Recall and Seat Belt Safety: Are You Driving in Danger?

Certain airbags and seat belts are subject to safety concerns.

Biotech

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Shire isn't obligated to spend AbbVie's money, but it's no fun speculating about earned interest. Which drug companies might be takeout targets for Shire?

Ebola Stocks May Be Overpriced as Fundamentals Outweigh Fear

Ebola stocks have soared in recent weeks but a closer look at fundamentals may serve as a reality check for investors playing the story.

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

Beyond Wall St.

Deal News

Royal Dutch Shell Sets IPO Price Range for U.S. Pipeline Operator

The Anglo-Dutch group expects proceeds of at least $711 million from the sale of almost a third of Shell Midstream Partners.

Cramer: Buy Small Oil Companies on This Next Leg Down

Big oil should start buying smaller oil.

Moment of Truth as Caesars Enters Into Formal Talks With Bank Lenders

Some observers believe the troubled casino operator will try to convince these powerful creditors to become involved in some large decisions.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer On China's Economic Data: Focus On Baltic Freight

Jim Cramer shares insight on the latest economic data out of China and stresses the importance of focusing on the nation's baltic freight data.

Herb Greenberg

Greenberg: Some Tech Companies Should Stop Giving Forecasts

IBM proves the fallacy of a long-term estimate.

Stephanie Link

Stephanie Link: You Can Still Find Value in this Pullback

Action Alerts PLUS has been buying into it.

Chris Ciaccia

Here's Why You Can't Use Apple Pay at Chipotle, Just Yet

Apple's mobile payments initiative Apply Pay is a success so far, according to CEO Tim Cook, but there's one major place you can't use it yet: Chipotle.

Adam Feuerstein

Some Potential Targets for Shire to Buy With $1.6B in Free Money

Shire isn't obligated to spend AbbVie's money, but it's no fun speculating about earned interest. Which drug companies might be takeout targets for Shire?

Dan Freed

Why Getting a Mortgage Should Soon Be a Little Bit Easier

Bankers and regulators are optimistic they will soon have an agreement intended to ease lenders' concerns.

Ted Reed

Delta to Wall Street: Don't Tell Us How to Run Our Airline

Delta is widely seen as the leading U.S. airline, yet some Wall Street analysts have decided it is adding too much capacity, breaking the mold of 'capacity discipline.'

Leon Lazaroff

Lions Gate Joins Online Video Party in Deal With Tribeca

Lions Gate is joining with Tribeca Enterprises as more TV and movie producers seek to start online subscription services.

Submit an article to us!
DOW 16,558.94 +159.27 0.97%
S&P 500 1,933.21 +29.20 1.53%
NASDAQ 4,392.3840 +76.31 1.77%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs